Related Experiment Video
Updated: Jun 12, 2026

Modeling Paracrine Noncanonical Wnt Signaling In Vitro
Published on: December 10, 2021
[Effect of Meisoindigo on Wnt signal pathway in K562 and HL-60 cells]
Ming-Xin Zuo1, Yan Li, Jian-Hua Zhou
1Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Abstract:
The aim of this study was to investigate the effect of meisoindigo on Wnt signal pathway in K562 cells and HL-60 cells and its possible regulatory mechanism. RT-PCR and Western blot assay were used to detect the expression of GSK-3beta and its downstream associated genes as well as proteins expression respectively. The results showed that the meisoindigo could inhibit the phosphorylation of GSK-3beta and decreased beta-catenin and c-myc genes expression in HL-60 cells, but did not significantly affect the two gene expression in K562 cells. Meisoindigo slightly increased the expression of GSK-3beta protein in HL-60 cells, obviously decreased the expression of p-GSK-3beta and c-MYC proteins in K562 cells and HL-60 cells, while meisoindigo did not affect the expression of beta-catenin in K562 cells significantly, but could decrease the expression of beta-catenin in HL-60 cells. It is concluded that the meisoindigo can affect the Wnt signal pathway through inhibiting the GSK-3beta expression and down-regulating the beta-catenin and c-MYC protein expression, which play an important role in the treatment for chronic myeloid leukemia.
Insights
Meisoindigo impacts the Wnt signaling pathway by inhibiting GSK-3beta and down-regulating beta-catenin and c-MYC. This mechanism is crucial for treating chronic myeloid leukemia.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- The Wnt signaling pathway is implicated in various cancers, including chronic myeloid leukemia (CML).
- Understanding the regulatory mechanisms of this pathway is crucial for developing effective cancer therapies.
Purpose of the Study:
- To investigate the effect of meisoindigo on the Wnt signaling pathway in K562 and HL-60 cells.
- To elucidate the regulatory mechanism of meisoindigo in these leukemia cell lines.
Main Methods:
- Reverse transcription-polymerase chain reaction (RT-PCR) was used to detect gene expression.
- Western blot assay was employed to analyze protein expression levels.
Main Results:
- Meisoindigo inhibited GSK-3beta phosphorylation and decreased beta-catenin and c-MYC gene expression in HL-60 cells.
- In K562 cells, meisoindigo significantly decreased p-GSK-3beta and c-MYC protein expression but did not affect beta-catenin.
- Meisoindigo decreased beta-catenin protein expression in HL-60 cells.
Conclusions:
- Meisoindigo modulates the Wnt signaling pathway by inhibiting GSK-3beta and down-regulating beta-catenin and c-MYC.
- These findings suggest meisoindigo's potential as a therapeutic agent for chronic myeloid leukemia.
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
